Answers are grounded in this paper and cite their sources.
Mycobacterium tuberculosis remains a threat to global health, and a more efficacious vaccine is needed to prevent disease caused by M. tuberculosis . We previously reported that the mycobacterial ribosome is a major target of CD4+T cells in mice immunized with a genetically modified Mycobacterium smegmatis strain (IKEPLUS) but not in mice immunized with Mycobacterium bovis BCG.
No takes yet. Share an insight, caveat, or question.
Kennedy et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: